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ABSTRACT 
Materials MIL-53(Fe), MIL-88(Fe) and MIL-100(Fe) have the ability to absorb many 
different compounds. In addition, the materials are small in size, highly bio-compatible, with no 
human toxicity. These materials were chosen to carry 5-fluorouracil (5-FU) for cancer treatment. 
Synthetic materials were characterized by scanning electron microscopy (SEM), X-ray 
diffraction (XRD) and surface characteristics (BET). 5-FU loading and releasing ability of MIL-
53(Fe), MIL-88(Fe) and MIL-100(Fe) have been investigated by UV-Vis spectrophotometer. 
The results showed that the MIL-53(Fe), MIL-88(Fe), and MIL-100(Fe) are capable of carrying 
5-FU with capacity exceeding 0.131 g/g, 0.28 g/g, 0.66 g/g respectively and mostly released 
after 10 days. The cancer cell toxicity and slow drug release ability of MIL(Fe)@5-FU were also 
tested by in-vitro method. Iron-organic frameworks are promising materials for cancer treatment.  
Keywords: MIL-53 (Fe), MIL-88 (Fe), MIL-100 (Fe), drug delivery, 5-FU, cancer treatment. 
1. INTRODUCTION 
The 5-fluorouracil molecule (C4H3FN2O2) of molar mass 130.1 g is relatively small. 
Because it contains both hydrogen bond donors and acceptors (N-H and C=O groups) it has the 
ability to shape co-crystals or salts after combination with other molecules, that could enhance 
the biological properties. 5-Fluorouracil (5-FU) is a chemotherapeutic agent employed in the 
treatment of several solid, such as breast, colorectal, and head and neck cancers. It has a broad 
spectrum of activity against various types of cancer and has a mode of action based on 
interfering with thymidylate synthesis. This leads to apoptosis in cancerous cells. The main 
challenge of using 5-FU is its short biological half-life, low selectivity and toxic side effects on 
the bone marrow and gastrointestinal tract [1]. In order to reduce these limitations, drug delivery 
systems have been considered for the controlled release of 5-FU drug to target site [2, 3]. 
Literature precedent shows that mesoporous silica nanoparticles [4], nano-gels [5], chitosan 
nanoparticles [6], cationic cyclo-dextrin/alginate chitosan nano-flowers [7], magnetic 
nanoparticles [8], metal-organic frameworks (MOFs) (transition metal except iron) [9, 10] have 
been used as potential systems for 5-FU drug delivery. 
Recently, MOFs has become a hotspot in the field of material science and undergone a 
rapid development because of the multifunctional nature [11-19]. New ordered porous MOFs 
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exhibit a series of advantages like large surface area, tunable structure and composition, 
adequate biocompatibility and natural biodegradability. A family of biodegradable MOFs, based 
on Fe(III) clusters and polycarboxylate ligands, has been synthesized [20, 21] and recently 
transposed under the nanoscale regime following “green” technology [22−24]. Such materials 
proved to act as efficient “molecular sponges”, rapidly soaking important amounts of 
hydrophilic and hydrophobic drugs directly from aqueous solutions [25]. Iron-organic 
frameworks - MIL(Fe) have been studied for its application in catalysis, environmental 
treatment, drug delivery, gas storage, etc. [26-29] 
In its application as a drug carrier, MIL(Fe) have been studied for the application of 
ibuprofen, acetaminophen [30, 31]. We have synthesized MIL-100(Fe), MIL-101(Fe) for gas 
(NOx, CO) and volatile organic compound adsorption. In this study, we present results of 
MIL(Fe) synthesis and applicability in drug delivery for 5-FU by evaluation of loading-release 
and toxicity of the drug carrier system. 
2. EXPERIMENTAL SECTION 
2.1. Chemicals 
Chemicals which were provided by Sigma-Aldrich: Terephtalic acid (C6H4(COOH)2),               
≥ 99 %; trimesic acid (C6H3(COOH)3), ≥ 95 %; Iron (III) chloride hexahydrate (FeCl3.6H2O), ≥ 
99 %; Dimethyl-formamide (DMF), HCON(CH3)2, ≥ 99.5 %; Ethanol (C2H5OH), 96 %; pure 5-
fluorouracil (5-FU); phosphate buffered saline (PBS); Trichloroacetic acid (TCA); 
Sulforhodamine B (SRB). 
2.2. Materials synthesis 
The synthesis process is referred from our previous studies with the highest efficiency 
conditions: 
- MIL-53(Fe) nanoparticles were synthesized at room temperature by ultrasonic method. 
0.83 g of terephthalic acid (H2BDC) and 1.35 g of FeCl3.6H2O were dissolved in 25 ml of DMF 
in a glass beaker. It was sealed and placed in an ultrasonic tank with a frequency of 20 kHz and 
capacity of 100 W in 7 hours. 
- MIL-88(Fe) nanoparticles were synthesized at room temperature by ultrasonic method. 
0.270 g FeCl3.6H2O is dissolved with distill water and add 0.166 g H2BDC in 5 ml DMF for 15 
mins in ultrasonic machine with a frequency of 20 kHz and capacity of 400 W. 
- MIL-100(Fe) nanoparticles were synthesized at room temperature by sol-gel process. 
FeCl3.6H2O is dissolved with distill water and added slowly trimesic acid (H3BTC) 5.10
-3
 M for 
1 hour under magnetic stirring. 
- After the reaction, the product was repeatedly washed with double-distilled water and 
ethanol. The material was dried at 80 
o
C in 8 hours. 
2.3. Characterization 
XRD patterns of materials were determined by the PXRD instrument (X’Pert Pro) using 
Cu-K  radiation in a range of 5 to 40
o 
at the Institute of Chemistry and Materials, Academy of 
Military Science and Technology. Morphologies of the materials were investigated by scanning 
electron microscopy (SEM) with different magnification at Institute of Materials Science, 
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Vietnam Academy of Science and Technology. BET surface areas, pore size distribution, and 
pore volume were measured by nitrogen adsorption/desorption iso-therms, at 393 K on a 
Quantachrome instrument at Institute of Chemistry, Vietnam Academy of Science and 
Technology. The 5-FU concentrations were analyzed by UV-Vis spectroscopy from 200 nm to 
400 nm at the Institute of Chemistry and Materials, Academy of Military Science and 
Technology. 
2.4. Drug loading and release 
- Drug loading experiment was carried out with 0.01 g material in 1 ml 5-FU 10 g/l for 72 
hours. The product was filtered, dried at 80 
o
C in 3 hours.  
- 0.01 g of loaded material was immersed in 20 ml DMF for 24 hours at room temperature.  
The drug-released MIL(Fe) was gotten out of mixture by centrifugation (15 min, 6000 
round/min) and determined the drug concentration. The 5-FU concentration was determined by 
UV-Vis spectrometry at wavelength λmax = 265 nm. The equation of 5-FU calibration curve is 
defined as y = 20. (0.042x - 0.013) where y is the optical absorption Abs. The amount of drug 
loaded inside the material is calculated by the formula:  
Q = m5-FU/mMIL(Fe) (g/g). 
- The drug-loaded MIL(Fe) was placed in a vial and dipped in 5 mL of a dissolution 
medium (phosphate buffer solution - PBS), pH 7.4 at 37
o
C. At predetermined time intervals, the 
dissolution medium was collected by centrifugation and determined the drug concentration. The 
5-FU concentration was analyzed by UV-Vis spectroscopy. The efficiency of drug release from 
the material is calculated according to the following formula: 
Htime = 100×Q/Qmax (%) 
where: Qmax is the maximum load capacity of material. 
2.5. In-vitro cytotoxic assay 
The cancer cell inhibition ability was evaluated by in-vitro cytotoxic assay designed by the 
National Cancer Institute, on breast carcinoma human cancer cell line - MCF7. The experiments 
were performed at Institute of Biotechnology, Vietnam Academy of Science and Technology. 
The goal of cytotoxicity assay is to screen, detect substances that inhibit the growth or 
destruction of cancer cells in in-vitro conditions, through determining cellular protein content 
after dyeing with sulforhodamine B by measuring optical density OD at 515-540 nm. MCF7 
breast cancer cells were precultured in 96-well microplates (7000 cells per well) for 24 h and 
then incubated with 5-FU (20.0-0.8 μg/ml) for different times.  
3. RESULTS AND DISCUSSION 
3.1. Material characterization 
The chemical composition of the material was characterized by XRD technique showed in 
Figure 1. XRD pattern of the sample (Figure 1) can confirm that the crystal phase of the product 
is MIL(Fe) due to monoclinic symmetry [32].  
 
 




Figure 1. The XRD pattern of the MIL(Fe) materials. 
 
Figure 2. The SEM images of the MIL-53(Fe), MIL-88(Fe), MIL-100(Fe) materials. 
The morphology of the synthesized materials was observed by SEM method and shown in 
Figure 2. The SEM images show that the morphology of the materials is different. These 
differences relate to the conditions of synthesis and crystallization of the product including the 
ratio of reagents, solvents, synthetic techniques. The synthesized MIL(Fe) crystals are small, 
complete, homogeneous and have diameters of 200 nm to 500 nm. This size makes the material 
easy to move in the human body, especially in blood vessels. 
The surface area and pore diameter are critical factors for drug adsorption and release in 
porous frameworks as drug delivery systems. The surface area of the materials measured by the 
N2 adsorption isotherm was shown in Table 1 below. The surface characteristics of the materials 
are different. The MIL-88(Fe) has the smallest surface area and pore diameter compared to the 
other two materials. Meanwhile, the surface area of MIL-100(Fe) material is much larger than 
MIL-53(Fe) and MIL-88(Fe).  
Table 1. Surface area, volume pore and diameter pore of the MIL(Fe) materials. 
Materials Surface area SBET (m
2
/g) Volume pore (cm
3
/g) Diameter pore (nm) 
MIL-53(Fe) 35.01 0.210 - 0.250 29.07 - 32.37 
MIL-88(Fe) 17.42 0.032 - 0.034 8.05 - 9.00 
MIL-100(Fe) 1,579.61 0.230 - 0.580 2.41 - 4.82 
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The surface area of the materials are related to its morphological state. As can be seen, 
MIL-53 exists in the "inhaled" state, so the value of surface area is quite low, but when it is 
saturated, it is maximally dilated [33]. For the MIL-88, the shape exists in long form just like 
grain and flexible structure [34]. Meanwhile, the MIL-100 has unchanged structure under 
different conditions. The results were found that, MIL-100(Fe) had the highest surface area 
(BET) and best storage capacity out of three MIL(Fe) samples equivalent to ZIF and MOF(Zn) 
[35, 17]. These surface parameters are related to the ability to carry and release drugs. The 
higher the surface area, the higher the carrying capacity. However, the higher the pore size, the 
faster the drug is released. The ability to bring and release drugs (5-FU) of these materials is 
presented in the next section. 
3.2. Drug loading - release ability evaluation  
By determining the 5-FU concentration in the DMF solution, the drug carrying capacity of 
MIL(Fe) materials was evaluated. The maximum load capacity of MIL-53(Fe), MIL-88(Fe) and 
MIL-100(Fe) corresponding to 0.131 g/g, 0.28 g/g and 0.66 g/g. This shows that the higher the 
surface area of the material, the higher the drug content in the material. However, this increase is 
not linear. Although the surface area of the MIL-100(Fe) is 90 times higher than the MIL-
88(Fe), and 45 times higher than the MIL-53(Fe), the drug loading of MIL-100(Fe) is 2 to 5 
times more than that of the MIL- 88(Fe) and MIL-53(Fe). Part of this may be due to the fact that 
the MIL-53(Fe) and MIL-88(Fe) are present in the "inhaled" state, so the surface area of these 
two materials is low. When they are absorbents, they are in the "hatching" state, so they can 
carry more drugs. 
To determine the drug release ability, 0.01 g of the loaded material was soaked in 5 ml PBS 
solution at 37 
o
C in different times and 5-FU concentration was measured. The results of drug 
release capacity are shown in Table 2 below: 
Table 2. The results of 5-FU release of MIL(Fe) at different times. 
No. t, hours 
MIL-53(Fe) MIL-88(Fe) MIL-100(Fe) 
Ct, mg/l H, % Ct, mg/l H, % Ct, mg/l H, % 
1 0.25 60.286 23.01 115.749 20.67 261.037 19.78 
2 2 92.762 35.41 174.392 31.14 483.290 36.61 
3 16 163.952 62.58 290.196 51.82 882.064 66.82 
4 24 177.571 67.78 307.199 54.86 875.427 66.32 
5 48 190.286 72.63 310.166 55.39 865.800 65.59 
6 72 209.762 80.06 358.693 64.05 983.783 74.53 
7 120 243.190 92.82 430.447 76.87 1,160.019 87.88 
8 168 256.952 98.07 408.554 72.96 1,192.259 90.32 
9 240 258.619 98.71 444.825 79.43 1,210.337 91.69 
Drug release efficiencies of all three materials in the first 15 minutes were quite similar and 
reached about 20 %. However, the 5-FU release rate of the materials is different. To achieve 
more than 80 % efficiency, MIL-53(Fe) material takes only 3 days. Meanwhile, after 3 days 
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MIL-100(Fe) only released 74.53 % drug content. And the drug release rate of MIL-88(Fe) only 
reached 79.43 % take up to 10 days. Other materials loading 5-FU had shorter release time, for 
example, NH2(CH3)2[Zn3(L)2·3.5DMF] loading 5-FU 0.22 g/g had released 92 % of the drug for 
only 120 hours [17]. 
3.3. Activity of MIL-Fe@5-FU system on cancer cells 
The cytotoxicity of 5-FU in MCF7 cells was evaluated based on its effect on cell growth by 
using the cytotoxic assay. The cytotoxicity of 5-FU was dose-dependent, the maximum cell 
death seen at concentration of 20 μg/ml. The evaluated results of the suppression of cancer cell 
over time are presented in Table 2 below, with IC50 is concentration of drug at which 50 % of the 
target is inhibited: 





5-FU MIL-53(Fe)@5-FU MIL-88(Fe)@5-FU MIL-100(Fe)@5-FU 
24 3.38  0.32 8.97  1.01 16.27  2.41 13.72  2.53 
48 3.09  0.48 6.72  0.45 9.64  1.52 9.41  1.63 
72 2.48  0.17 5.25  0.73 7.09  0.68 6.09  0.97 
96 2.38  0.19 3.77  0.11 6.48  0.57 5.87  0.67 
120 1.65  0.18 3.75  0.40 5.18  0.61 4.68  0.51 
The results of the cytotoxicity test show that the MCF7 cells inhibitory capacity of different 
systems is different. As time increases, the inhibitory capacity on the cancer cells of all materials 
increases. However, this increase from the material is different. This result is related to the slow 
release of drugs from the carrier materials. The slower the release of drugs, the lower the 
inhibitory capacity. In Ref. 36, the IC50 values of 5-FU@DsAgNCs on MCF7 cells was 1.5 
μg/mL. This shows that the slow release of these carriers is limited. From the results in Table 3, 
MIL-100(Fe) has the best storage capacity. Meanwhile, MIL-53(Fe) release drugs out of the 
material faster. However, the choice of material as carrier depends on other factors such as 
particle size, biological compatibility of the system, etc. Therefore, we are studying the 
biometric compatibility and the orientation to select the MIL(Fe) materials of cancer treatment 
applications. 
4. CONCLUSION 
The MIL(Fe) materials were successfully synthesized from FeCl3 salt and poly-carboxylic 
acid. The morphology of the materials is different with the particle size ranges from 200 nm to 
500 nm. The results were found that, MIL-100(Fe) had the highest surface area (BET) and best 
storage capacity out of three MIL(Fe) samples. With many advantages such as high carrying 
capacity, long lasting storage, small size, good bio-compatibility and high toxicity on cancer 
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cells, MIL(Fe) material is promising material for drug delivery on cancer treatment. 
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